Company Long-Term Loans and Borrowings: Pharming (PHAR)

Public company logo of Pharming Group NV (PHAR)

Pharming Group N.V. (PHAR) generates revenue from exclusive drugs for the therapy of rare immune pathologies, relying on multi-year patent protection. The business possesses full pricing power due to its monopoly in the field of recombinant protein synthesis. Dependence on external purification plants is mitigated by long-term contracts, and the indicator stands at 0.11. This chart illustrates the company's price action and quote dynamics.

PHAR Pharming Group N.V. Company Long-Term Debts (07/04/2022 - 10/29/2026)

Pharming (PHAR) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price pharming.com|PHAR - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Pharming Group|PHAR - Total Company Value
- book capitalization information:
Accounting Value per Share Pharming Group|PHAR - Book Capitalization|Market Capitalization to Book Value Ratio pharming.com|PHAR - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Pharming Group N.V.|PHAR - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Pharming Corp|PHAR - Company Debts|Debt to Book Value Pharming Group|PHAR - Company Long-Term Debt|Company Current Liabilities Pharming Group
Analysis of all company metrics:PHAR - pharming.com
Brand item of Pharming Group N.V.

Assessing the financial stability of Pharming Group N.V. (PHAR) requires an analysis of liabilities with maturities exceeding one year, which determine the cost of servicing leverage and the risk of liquidity gaps. By analyzing the business's long-term debt metrics, an investor can discern the balance between debt load and investments in the therapeutic protein platform, which ensures high margins due to its monopoly position in rare disease niches.

Competitors of Pharming Group N.V. (PHAR)

Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CLDX (Celldex)|Long-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|Company Long-Term Liabilities ABCL|Company Long-Term Debts Tourmaline|Company Long-Term Debt Precigen, Inc. (PGEN)|nektar.com - Company Long-Term Indebtedness|Company Long-Term Debts UPB (Upstream Bio)|Zenas Bio (ZBIO) - Long-Term Debt|IMNM - Company Long-Term Debt|Long-Term Liabilities GOSS|KALV: Company Long-Term Debts|septerna.com - Company Long-Term Loans and Borrowings|PVLA (Pieris Pharmaceuticals, Inc.) - Company Long-Term Debts|Company Long-Term Debts Savara Inc|Company Long-Term Debt Rigel Pharmaceuticals Inc (RIGL)|ANAB (AnaptysBio Inc.) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Astria Therapeutics ATXS|ENGN - Company Long-Term Liabilities|RAPT Therapeutics, Inc. - Company Long-Term Debts|Long-Term Debt Volume Aerovate Therapeutics Inc JBIO|Aclaris (ACRS) - Company Long-Term Debt|Company Long-Term Indebtedness KYTX|TLSA (Tiziana Life Sciences) - Company Long-Term Debts|CABA - Long-Term Indebtedness|Company Long-Term Liabilities VTYX (Ventyx Biosciences, Inc.)|THTX (Theratechnologies, Inc.) - Company Long-Term Loans and Borrowings|Company Long-Term Debts AVTX (Avalo Therapeutics Inc.)|Long-Term Indebtedness Eledon Pharmaceuticals, Inc|AGEN - Company Long-Term Debt|Company Long-Term Loans and Borrowings CLYM (climbbio.com)|Zura Bio Limited (ZURA) - Company Long-Term Debt|Long-Term Debt aTyr Pharma Inc (ATYR)|Company Long-Term Liabilities ADAG|Company Long-Term Debts Ikena Oncology, Inc.|Company Long-Term Debt Shattuck Labs, Inc. (STTK)|EQ: Long-Term Liabilities|Connect Biopharma Holdings Limited - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings IMUX|ATRA - Company Long-Term Debt|IFRX (InflaRx N.V.) - Company Long-Term Indebtedness|XFOR (X4 Pharmaceuticals) - Company Long-Term Liabilities|ACET - Long-Term Debt Volume|Company Long-Term Liabilities CELU|Company Long-Term Debt INMB|Company Long-Term Liabilities BRNS (Barinthus Bio)|Long-Term Debt Volume Kezar Life Sciences Inc|Company Long-Term Debt SAB Biotherapeutics SABS|AKTX (akaritx.com) - Long-Term Liabilities|Enlivex Therapeutics, Ltd. - Company Long-Term Debts|Company Long-Term Loans and Borrowings QTTB (Q32 Bio Inc.)|GOVX: Company Long-Term Debts|Edesa Biotech Corp (EDSA) - Company Long-Term Debts|Company Long-Term Debt iBio, Inc.|CARM: Company Long-Term Loans and Borrowings|Company Long-Term Debt XTL Biopharmaceuticals Ltd. (XTLB)|BOLT: Long-Term Liabilities|Company Long-Term Debts HCWB (HCW Biologics)|Company Long-Term Loans and Borrowings APVO|AIM ImmunoTech - Company Long-Term Debts|ADTX - Company Long-Term Debts|GRI Bio (GRI) - Company Long-Term Debt|XORTX Therapeutics Inc - Company Long-Term Loans and Borrowings|Company Long-Term Debt ReShape Lifesciences|Company Long-Term Liabilities Revelation Biosciences Corp (REVB)|Company Long-Term Debts INDP|Company Long-Term Debts scinai.com (SCNI)|CalciMedica - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings AFMD|Allakos Therapeutics - Company Long-Term Debts|Long-Term Debt Volume HOOKIPA Pharma Inc. HOOK|igmbio.com (IGMS) - Company Long-Term Debt|Company Long-Term Liabilities iteostherapeutics.com|Company Long-Term Debt Ocean Biomedical|Company Long-Term Liabilities TC BioPharm (Holdings) Plc (TCBP)|Company Long-Term Liabilities THRD (Third Harmonic Bio, Inc)